Patients with critical COVID-19 have been found to have higher serum levels of Gal-3, along with increased proinflammatory cytokines (IL-1β, TNF-α, IL-12) and chemokine C-C chemokine receptor type 5 (CCR5) expression in T cells [22]. This evidence concerns the gene CCR5 and COVID-19.